MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.

* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 

Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials

Liu T et al. – No significant effects of n–3 PUFA supplementation on atrial fibrillation (AF) prevention were observed in this meta–analysis. A large–scale trial with higher doses and longer follow–up might be required to rule out the possibility of any treatment benefit.

  • MEDLINE, Web of Science and Cochrane clinical trials database were searched until November 2010
  • Of 127 initially identified studies, 10 RCT with 1955 patients were finally analysed
  • Two blinded reviewers extracted data independently to a predefined form. Disagreements were resolved through discussion and consensus

  • n–3 PUFA had no significant effect on the prevention of AF (OR 0.81, 95% CI 0.57 to 1.15; p=0.24)
  • There was significant heterogeneity among the studies (p=0.002, I2=65.0%)
  • Subgroup analysis showed no significant beneficial effect of fish oils in any subset of population

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More